Knight Initiative News

Knight Initiative–supported research by Pascal Geldsetzer and colleagues adds to evidence that preventing the viral infection can help stave off cognitive decline.

New Alzheimer's biomarkers focus on whether Alzheimer's has actually begun to affect a person's thinking and memory, rather than just amyloid levels.

Psychiatrist Anna Lembke shares what scientists have discovered so far about the potential for GLP-1s in addiction treatment.

Young adults crave closeness, says Stanford psychologist Jamil Zaki, but often misjudge how much their peers want that, too. His research found strategies that can help nudge people to take a chance on one another.

In a recent study of a technique to help kids with ADHD strengthen their working memory, about half of participants showed improvements in their symptoms. The concept also offers promise for treating other neuropsychiatric conditions.

This week on the podcast, Stanford radiology faculty Kim Butts Pauly and Raag Airan help us dive deep into the brain with focused ultrasound

Neurotech trainee Favour Nerrise is among 10 grad students who will have three minutes to engage the audience—and a panel of judges—with their research projects at the April 17 event emceed by Stanford president Jonathan Levin.

By studying never-before-seen details of brain connectivity in human infants, researchers at the Wu Tsai Neurosciences Institute have identified how a balance of innate structure and flexible learning produces our remarkably organized visual brains.

In the lab of Lauren O’Connell, associate professor of biology, researchers look to amphibian species to learn how animals evolve in response to changing environments.

Three teams developing promising neurotechnologies with the potential for tremendous impact on human well-being have been named recipients of the 2025 Neuroscience:Translate awards from the Wu Tsai Neurosciences Institute at Stanford.

Our brains and digestive tracts are in constant communication. When that communication goes off the rails, research suggests diseases and disorders can result.

This week on the podcast, Stanford psychiatry professor Erin Gibson joins us again to share the latest findings on sleep, myelin, and neurodegenerative disease.

Stanford researchers have created a compound that relieves multiple types of pain in mice without building tolerance or causing psychoactive side effects.

Gordon Wang, director of the Neuroscience Microscopy Service Community Lab at Wu Tsai Neuro, and his team are studying integrated stress response inhibitor (ISRIB) as a potential treatment for Fragile X syndrome, aiming to restore brain function and improve social behavior.

New findings about the sugary armor on the brain’s frontline cells could shed light on cognitive decline and diseases like Alzheimer’s—and open new avenues for treatment.

 

Stanford Medicine spoke with neurologist Helen Bronte-Stewart, who conducted research that led to the development of a technology recently approved by the U.S. Food and Drug Administration.

The 1970s papers from Goldberg and Wurtz made ambitious mechanistic studies of higher brain functions seem feasible.

How does the brain wire itself for learning? What molecular mechanisms protect neural circuits during aging? These are just some of the research projects by the 2025 Neurosciences Postdoctoral Scholars.

Associate professor Jason Yeatman discusses the adoption of the Stanford-developed Rapid Online Assessment of Reading (ROAR) as a state-approved dyslexia screening tool in California.

Mice learn fastest and most reliably when they experience an increase in dopamine paired with an inhibition of serotonin in their nucleus accumbens, a new study shows, helping to resolve long-standing questions about the neuromodulators’ relationship.